Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 51
1993 62
1994 67
1995 77
1996 1
1997 12
1998 10
1999 92
2000 92
2001 100
2002 101
2003 168
2004 170
2005 227
2006 452
2007 369
2008 238
2009 319
2010 280
2011 263
2012 274
2013 260
2014 285
2015 316
2016 271
2017 300
2018 268
2019 297
2020 462
2021 338
2022 319
2023 117
Text availability
Article attribute
Article type
Publication date

Search Results

6,317 results
Results by year
Filters applied: . Clear all
Page 1
Updates in the treatment of vaginal cancer.
Jhingran A. Jhingran A. Int J Gynecol Cancer. 2022 Mar;32(3):344-351. doi: 10.1136/ijgc-2021-002517. Int J Gynecol Cancer. 2022. PMID: 35256422 Free PMC article. Review.
Human papillomavirus-independent cervical cancer.
Fernandes A, Viveros-Carreño D, Hoegl J, Ávila M, Pareja R. Fernandes A, et al. Int J Gynecol Cancer. 2022 Jan;32(1):1-7. doi: 10.1136/ijgc-2021-003014. Epub 2021 Nov 1. Int J Gynecol Cancer. 2022. PMID: 34725203
Endometrial carcinosarcoma.
Bogani G, Ray-Coquard I, Concin N, Ngoi NYL, Morice P, Caruso G, Enomoto T, Takehara K, Denys H, Lorusso D, Coleman R, Vaughan MM, Takano M, Provencher DM, Sagae S, Wimberger P, Póka R, Segev Y, Kim SI, Kim JW, Candido Dos Reis FJ, Ramirez PT, Mariani A, Leitao M, Makker V, Abu-Rustum NR, Vergote I, Zannoni G, Tan D, McCormack M, Paolini B, Bini M, Raspagliesi F, Benedetti Panici P, Di Donato V, Muzii L, Colombo N, Pignata S, Scambia G, Monk BJ. Bogani G, et al. Int J Gynecol Cancer. 2023 Feb 6;33(2):147-174. doi: 10.1136/ijgc-2022-004073. Int J Gynecol Cancer. 2023. PMID: 36585027 Review.
Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001.
Marth C, Tarnawski R, Tyulyandina A, Pignata S, Gilbert L, Kaen D, Rubio MJ, Frentzas S, Beiner M, Magallanes-Maciel M, Farrelly L, Choi CH, Berger R, Lee C, Vulsteke C, Hasegawa K, Braicu EI, Wu X, McKenzie J, Lee JJ, Makker V. Marth C, et al. Int J Gynecol Cancer. 2022 Jan;32(1):93-100. doi: 10.1136/ijgc-2021-003017. Epub 2021 Nov 19. Int J Gynecol Cancer. 2022. PMID: 34799418 Free PMC article.
ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA-MONO) and rucaparib in combination with nivolumab (ATHENA-COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer.
Monk BJ, Coleman RL, Fujiwara K, Wilson MK, Oza AM, Oaknin A, O'Malley DM, Lorusso D, Westin SN, Safra T, Herzog TJ, Marmé F, N Eskander R, Lin KK, Shih D, Goble S, Grechko N, Hume S, Maloney L, McNeish IA, Kristeleit RS. Monk BJ, et al. Int J Gynecol Cancer. 2021 Dec;31(12):1589-1594. doi: 10.1136/ijgc-2021-002933. Epub 2021 Sep 30. Int J Gynecol Cancer. 2021. PMID: 34593565 Free PMC article. Clinical Trial.
Impact of hypoxia on cervical cancer outcomes.
Datta A, West C, O'Connor JPB, Choudhury A, Hoskin P. Datta A, et al. Int J Gynecol Cancer. 2021 Nov;31(11):1459-1470. doi: 10.1136/ijgc-2021-002806. Epub 2021 Sep 30. Int J Gynecol Cancer. 2021. PMID: 34593564 Review.
SUCCOR cone study: conization before radical hysterectomy.
Chacon E, Manzour N, Zanagnolo V, Querleu D, Núñez-Córdoba JM, Martin-Calvo N, Căpîlna ME, Fagotti A, Kucukmetin A, Mom C, Chakalova G, Shamistan A, Gil Moreno A, Malzoni M, Narducci F, Arencibia O, Raspagliesi F, Toptas T, Cibula D, Kaidarova D, Meydanli MM, Tavares M, Golub D, Perrone AM, Poka R, Tsolakidis D, Vujić G, Jedryka MA, Zusterzeel PLM, Beltman JJ, Goffin F, Haidopoulos D, Haller H, Jach R, Yezhova I, Berlev I, Bernardino M, Bharathan R, Lanner M, Maenpaa MM, Sukhin V, Feron JG, Fruscio R, Kukk K, Ponce J, Minguez JA, Vázquez-Vicente D, Castellanos T, Boria F, Alcazar JL, Chiva L; SUCCOR study group; SUCCOR study Group. Chacon E, et al. Int J Gynecol Cancer. 2022 Feb;32(2):117-124. doi: 10.1136/ijgc-2021-002544. Epub 2022 Jan 17. Int J Gynecol Cancer. 2022. PMID: 35039455
Ovarian dysgerminoma.
Mohamed A, Ali A, Younis FM. Mohamed A, et al. Int J Gynecol Cancer. 2022 Nov 7;32(11):1490-1491. doi: 10.1136/ijgc-2022-003978. Int J Gynecol Cancer. 2022. PMID: 36343973 No abstract available.
6,317 results